How do I switch from NPH (Neutral Protamine Hagedorn) Humulin N (insulin isophane) to 70/30 insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Switching from NPH Insulin to 70/30 Insulin

When switching from NPH (Humulin N) insulin to 70/30 insulin, stop the NPH insulin and start twice-daily 70/30 insulin with the total daily dose equal to 80% of the previous NPH dose, typically dividing as 2/3 before breakfast and 1/3 before dinner. 1

Conversion Process

Initial Dosing

  • Calculate the total daily dose of 70/30 insulin as 80% of your current NPH insulin total daily dose 1
  • Divide the 70/30 insulin into two daily injections 1:
    • Give 2/3 of the total daily dose before breakfast
    • Give 1/3 of the total daily dose before dinner
  • For example, if you were taking 50 units of NPH daily, your new 70/30 insulin regimen would be approximately 40 units total (80% of 50), with 27 units before breakfast and 13 units before dinner 1

Timing of Administration

  • Administer 70/30 insulin before meals (typically 30 minutes before for human insulin mix) 2
  • 70/30 insulin contains 70% NPH (intermediate-acting) and 30% Regular (short-acting) insulin components 2

Monitoring and Adjustment

Blood Glucose Monitoring

  • Check blood glucose levels more frequently during the transition period 1
  • Monitor both fasting and postprandial glucose levels to assess the effectiveness of the new regimen 1
  • Target fasting glucose values between 4.0-7.0 mmol/L (72-126 mg/dL) 1

Dose Titration

  • Adjust the morning and evening doses separately based on blood glucose patterns 1
  • For hypoglycemia: determine the cause and if no clear reason is found, lower the corresponding dose by 10-20% 1
  • For persistent hyperglycemia: increase the dose by 1-2 units or 10-15% at a time 1

Clinical Considerations

Advantages of 70/30 Insulin

  • Provides both basal and prandial coverage with fewer daily injections 1
  • Simplifies the regimen compared to separate basal and bolus injections 1
  • May improve adherence due to convenience of premixed formulation 3
  • Studies show patients with poor control on self-mixed insulin regimens can safely transfer to premixed 70/30 insulin, often with improved glycemic control 3

Potential Challenges

  • Less flexibility in dosing compared to basal-bolus regimens 1
  • May not provide optimal coverage for variable meal timing or content 1
  • The fixed ratio may not match individual physiologic needs as precisely as separately adjusted basal and bolus components 1

Special Considerations

Hypoglycemia Risk

  • Monitor closely for hypoglycemia during the transition period, especially at night 1
  • Premixed insulin regimens may have different hypoglycemia risk profiles compared to NPH alone 4
  • Consider reducing the dose if A1C is <8% when switching to avoid hypoglycemia 1

Meal Timing

  • More consistent meal timing is important with premixed insulin regimens 1
  • The 30% regular insulin component addresses postprandial glucose excursions 2
  • The 70% NPH component provides intermediate-duration basal coverage 2

Common Pitfalls to Avoid

  • Don't convert on a 1:1 basis: Using 80% of the NPH dose when converting to 70/30 insulin helps prevent hypoglycemia 1
  • Don't use the same dose for both morning and evening: The 2/3 morning and 1/3 evening split better matches physiologic needs 1
  • Don't neglect monitoring during transition: More frequent glucose monitoring is essential during the switch 1
  • Don't forget about meal timing: 70/30 insulin should be administered approximately 30 minutes before meals for optimal effect 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.